Bruker Q4 Revenues up 9 Percent; Job Cuts Ahead

Feb 19, 2013

|

NEW YORK (GenomeWeb News) – Bruker today said that revenues for its fourth quarter rose 9 percent year over year, and it beat the average analyst estimates on the top and bottom lines.

Despite the strong finish to the year, a company official said on a conference call following the release of the results that restructuring initiatives are expected to result in layoffs this year.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Scan

More Details Wanted

Nature News writes that additional details about the UK plan for an agency to support high-risk, high-reward science are needed.

And a Third

The New York Times reports that the US Food and Drug Administration has authorized Johnson & Johnson's SARS-CoV-2 vaccine.

Glimpses of Viral Origins

The Wall Street Journal writes new studies are giving glimpses into the origins of SARS-CoV-2.

PLOS Papers on Plasmodium Falciparum Populations, Scabies Molecular Diagnostics, More

In PLOS this week: analysis of Plasmodium population structure, qPCR assay to diagnose scabies, and more.

Featured White Papers

Protein quantification and qualification

Protein Purification Using Immobilized Metal Affinity Chromatography (IMAC) with a VIAFLO 96/384 Handheld Electronic Pipette

Performing an ELISA with the ASSIST PLUS Pipetting Robot

Harnessing the Most Powerful Cells Crucial to Accelerating Curative Medicines

Mar

11

Featured Webinar

Virtual Molecular Tumor Board Series: Gene Fusions as Druggable Targets

In this session, the third in the Precision Oncology News Virtual Molecular Tumor Board Series, our expert panelists will review patient cases in which genomic profiling has identified gene fusions that may or may not serve as druggable targets.

Mar

17

Featured Webinar

Spatial Profiling of Metabolic Regulation in the Human Tumor Microenvironment Using Multiplexed Ion Beam Imaging

In this webinar, Felix J. Hartmann of Stanford University will describe an approach that characterizes the metabolic regulome of individual cells together with their phenotypic identity.

Mar

24

Featured Webinar

Single-Cell Analysis and Genome Editing in Preclinical Disease Modeling: Detailed Insights into Leukemia Lineage

This webinar, the first in a “Women in Single Cell” series sponsored by Mission Bio, will discuss the use of single-cell analysis to assess genome editing for use in pre-clinical disease modeling.

Apr

23

Featured Webinar

Advances in Single-Cell Proteomics: Building a Complete Picture of Cellular Identity

Recent advances in single-cell technologies have provided unprecedented -omic-level insights into cellular heterogeneity and function.

Menu

Bruker Q4 Revenues up 9 Percent; Job Cuts Ahead

To read the full story....

Breaking News

OraSure Technologies Q4 Revenues Rise 27 Percent, Beat Analysts' Estimate

NanoString Technologies Q4 Revenues Fall 2 Percent

Host DNA Methylation Signatures May Predict Likelihood of Persistent, Resolving MRSA Infections

Seqster, Medable Team on Data Integration for Clinical Trials

FDA Reissues EUA for Fluidigm SARS-CoV-2 Test for Use With Azova Home Collection Kit

Eurofins Scientific Posts 17 Percent Increase in FY2020 Revenues

The Scan

More Details Wanted

And a Third

Glimpses of Viral Origins

PLOS Papers on Plasmodium Falciparum Populations, Scabies Molecular Diagnostics, More

Featured White Papers

Virtual Molecular Tumor Board Series: Gene Fusions as Druggable Targets

Spatial Profiling of Metabolic Regulation in the Human Tumor Microenvironment Using Multiplexed Ion Beam Imaging

Single-Cell Analysis and Genome Editing in Preclinical Disease Modeling: Detailed Insights into Leukemia Lineage

Advances in Single-Cell Proteomics: Building a Complete Picture of Cellular Identity

What's Popular?

New Method Provides NGS-Based Readout of Glycan Levels in Single Cells

Sponsorships